Home › Forums › Main Forum › Patient Stories › Geopolitics › How will the signing of the TPP affect us?

Viewing 5 posts - 16 through 20 (of 20 total)
1 2
  • Author
    Posts
  • 29 February 2016 at 1:58 am #12952
    Avatar photoJoy
    • Guardian Angel
    • ★★★★★
    @joy

    For Australians concerned about the TPP – here’s today’s SumOfUs petition calling for an independent analysis:

    Our government is ferociously pushing to pass the Trans-Pacific Partnership (TPP), one of the biggest corporate power grabs in a generation, without any independent analysis.

    This comes amidst the World Bank’s estimates, which have told us that the deal will have practically no economic benefit to our country.

    The TPP will drastically push up the price of crucial life-saving medicines, trash our environment, and threaten our internet freedoms.

    http://action.sumofus.org/a/tpp-aus-inquiry/?akid=17441.4782804.A64TJT&rd=1&sub=fwd&t=1

    29 February 2016 at 2:13 am #12953
    Avatar photoTina-Hill-facebook
    • Guardian Angel
    • ★★★★★
    @tina-hill-facebook

    This is a recent article from the New Zealand Medical Journal and its commentary in relation to the TPPA.

    Generic protections for healthy public policy are fragmented, inconsistent and weak

    The TPPA does contain a number of provisions that governments can use to defend healthy public policies against foreign country or foreign company disputes (see Technical Barriers to Trade Chapter 8, Investment Chapter 9 and Annex 9B, Intellectual Property Chapter 18, Exceptions Chapter 29, Annex II New Zealand). However, the defences for health are illogical, incoherent and incomplete. The following illustrate this incoherent picture.

    Some clauses state a principle, some are for “protection”, others for “preservation”, others relate to “problems”, or offer “sensitivity to objectives”. Some are for “health”, others for “public health”. Human life, safety, nutrition and availability of medicines are sometimes named separately from health. While this messy terminology may reflect ignorance and piecemeal drafting, the vague wording of these health clauses contrasts with the precise language used in other areas of the Agreement (such as the explicit, extraordinarily broad definition of “investment” and the careful elaboration of other terms in the text to reduce doubt in interpretation). These ambiguous provisions could open governments to threats, delay tactics and disputes from foreign countries and foreign companies. It is far from clear how these unclear clauses would support, for example, the obesity and alcohol measures recommended by the New Zealand Medical Association.22,23

    http://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2016/vol-129-no-1430-19-february-2016/6809

    SVR 24

    29 February 2016 at 2:25 am #12954
    Avatar photo2b
    • Guardian Angel
    • ★★★★★
    @2b

    The tpp is bad news for every HUMAN on the planet, and corporations are NOT people (although our gov’t illogically says they are).

    GT 2b; since 80’s, no prior tx, sofosbuvir and daclatasvir compounded from API’s at Kingswood Pharmacy in Sydney, started tx nov 6,2015, undetected at 4 wks, UND at 8 weeks, UND at 1 week after EOT, UND at 4 weeks after EOT and UND at 8 weeks after EOT. I feel GOOD!! I knew that I WOULD!””

    29 February 2016 at 2:41 am #12955
    Avatar photosplitdog
    • Guardian Angel
    • ★★★★★
    @splitdog

    Agree wholeheartedly.

    splitdog@roadrunner.com

    Genotype 3
    VL 4,100,000
    ALT 101 AST 71
    Treatment Naive
    Started Sof/Dac Jan 12, 2016
    VL= <15 4 weeks in. AST/ALT normal.
    VL=UNDETECTED 8 weeks in.
    SVR4= Virus back. 3,300,000

    Started generic Epclusa Sep. 23, 2017

    4 weeks in <15 *Detected.
    12 weeks in <15 *Not Detected.
    16 weeks in <15 *Not Detected.
    Finished 24 weeks treatment 3-17-18
    SVR5 <15 Not Detected.
    SVR 20 <15 Not Detected.
    SVR 44 <15 Not Detected.

    Thank you Jesus.
    Thank you Dr. James

    29 February 2016 at 7:59 pm #12988
    Avatar photoTina-Hill-facebook
    • Guardian Angel
    • ★★★★★
    @tina-hill-facebook

    12794346_1671705363097191_6935645702696003986_n.png

    Pharmaceutical companies pushed for the extension of drug patents, data exclusivity, biologics exclusivity, and stringent copyright terms in the Trans-Pacific Partnership (TPP). Though they didn’t get everything they wanted — and are throwing a hissy fit demanding the TPP be renegotiated — is their claim that R&D justifies these demands accurate? Just exactly how much does Big Pharma pay for R&D of a new drug?

    A drug funded research team claimed R&D costs average $1.32 billion (in 2011 dollars) per drug. An analysis of this study finds the cost is closer to $75 million.

    1) FULL ARTICLE: http://slate.me/1eTb6SC (March 3, 2011)

    2) TPP INTELLECTUAL PROPERTY CHAPTER – PATENT PROVISIONS, P. 8-9: http://bit.ly/1P9quea

    3) BIG PHARMA UNHAPPY WITH TPP OUTCOME: http://bit.ly/1Qm0sUd

    SVR 24

  • Author
    Posts
Viewing 5 posts - 16 through 20 (of 20 total)
1 2
  • You must be logged in to reply to this topic.